NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108 | +3.8% | 180,630 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $104 | -86.8% | 180,630 | -48.0% | 0.01% | -88.6% |
| Q4 2022 | $786 | -99.9% | 347,612 | -27.0% | 0.04% | -52.2% |
| Q3 2022 | $1,525,000 | -7.3% | 476,412 | +10.0% | 0.09% | -25.8% |
| Q2 2022 | $1,645,000 | +317.5% | 433,000 | +493.1% | 0.12% | +376.9% |
| Q1 2022 | $394,000 | +44.3% | 73,010 | +234.6% | 0.03% | -82.8% |
| Q2 2015 | $273,000 | – | 21,820 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |